Senti Biosciences subsidiary issues $4.0M convertible notes to Celadon; potential $60M CVR merger pending

Senti Biosciences, Inc.

On Aug 14, 2026, Senti Holdings issued $4.0M principal Senior Secured Convertible Notes to Celadon Partners SPV 24.
Issuance under April 27, 2026 Securities Purchase Agreement; terms referenced from prior 8-Ks filed May 1 and May 26, 2026.
Potential deal: Celadon affiliate to merge with Senti Holdings, issuing CVR worth up to $60M upon SENTI-202 regulatory/sales milestones.
Preliminary proxy statement filed July 21, 2026; definitive proxy will be mailed to stockholders for vote.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.